For patients with heart failure or chronic kidney disease, SGLT2 inhibitors are generally preferred first, with GLP-1 agonists considered when SGLT2 inhibitors are contraindicated or not tolerated
Dosage Forms and Strengths 50 mg/500 mg tablets are light pink, capsule-shaped, film-coated tablets with "575" debossed on one side
Medical Writing/Editorial Assistance Medical writing support was provided by Kate Silverthorne, PhD, a contract writer working on behalf of Apollo, OPEN Health Communications, and William Townley, MRes, of Apollo, OPEN Health Communications, and funded by Novo Nordisk, under the direction of the authors and in accordance with Good Publication Practice (GPP) guidelines (www.ismpp.org/gpp-2022)
To overcome drug resistance and enhance its cytotoxicity, two derivatives of DOX were synthesized incorporating a sulfonamide moiety: 4-mononitrobenzenesulfonyl DOX (MNS-DOX) and 2,4-dinitrobenzenesulfonyl DOX (DNS-DOX) 94
Depletion of GSH as a consequence of acetaminophen toxicity to the liver has attracted the most attention in the medical scientific community, as it can frequently be fatal or require a liver transplant or emergency treatment to prevent liver failure (the liver is the organ with the greatest concentration of GSH)
Side Effects and Safety Profile Like any medication it does have potential side effects